Sign up
Pharma Capital
EPIC: HC
Market: CSE
52-week High/Low: C$1.48 / C$0.31
Sector: Medical Cannabis
Market Cap: C$40.76M
Website: highhampton.com

High Hampton Holdings Corp. is a cannabis sector investment company focused on opportunities in California. The Company's wholly owned subsidiary, CoachellaGro Corp., is a California corporation focused on the development of their 254,000 sq ft. greenhouse facility situated in the cannabis industrial park located in Coachella, California. CoachellaGro has received a conditional use permit...

High Hampton Holdings Corp

highhampton.com

Interactive graph

col 3
col 4
col 5
col 6

High Hampton Holdings Corp Snapshot

 

DAVID E. ARGUDO

Chief Executive Officer/Director

Current elected City Official 7+ years. Consults & develops cannabis policies for local municipalities. Pioneer in developing local tax measures of cannabis in California. 25 year career in cannabis with experience in biopharmaceuticals, cancer research, real estate and mortgage financing.

Member of California Growers Association, Member of Humboldt Interdisciplinary Institute for Marijuana Research (HiiMR).

RICHARD POLANCO

President/Director

Former California State Senate Majority Leader and Founder of the California Latino Legislative Caucus (1990). 
Career advocate for medicinal cannabis in California, and active proponent for Prop 64 legalization.

Currently a strategic advisor to a company focused on cannabis testing.
 

PAUL MANN

Chief Operating Officer

A successful serial entrepreneur, Paul Mann’s experience and network spans the globe. He has managed and successfully exited nine start-ups on three continents including Cavio Corporation, Veridicom International, National Connect, The Pacific Business Development Corporation and Winsight Technology.

 

 

 

 

 

 

 

 

 

 

CHRISTIAN SCOVENNA

Sr. VP of Corporate Finance/Director

Christian Scovenna has over eleven years of capital market experience. As Managing Director at a boutique firm, Mr. Scovenna lead six portfolio companies within the group, raising capital, business development.

He also spent four years with Frontier Merchant Capital Group as Director & Senior VP of Operations and most recently as Managing Partner with Lions Edge Capital.

Over the years, Mr. Scovenna has been successful in completing numerous M&A activities and capital raises. He currently serves as Director & Sr. VP of Business Development for Enforcer Gold Corp. (VEIN-TSX.V).
 

 

TOM SYKES

Sr. Human Resources / Risk Manager

Thomas Sykes has more than three decades of experience in the private and public sectors, having worked for the Union Pacific Railroad, Southwest Management Consulting, the City of Whittier, the State of California, the City of Commerce, the City of Industry, and managing his own consulting company.  

He is a retired City Administrator / Redevelopment Agency Executive Director for the City of Commerce, and also served in many other capacities during his 32 year career with Commerce, including Recreation Center Director, Management Analyst, Personnel Analyst,  Assistant Director of Special Services, Director of Personnel, and Assistant City Administrator.  As a 16 year elected member of the Walnut City Council, Thomas Sykes served 4 terms as Mayor, serving several years on the Southern California Joint Powers Insurance Authority Board of Directors, where he received his Risk Manager Certification. 

Thomas Sykes is a member of the Society for Human Resource Management and has a vast amount of experience in the Personnel, Labor Relations and Human Resources Management field.

ROBERT ALLEN

Director

Robert Allen, CA, is an investor, entrepreneur, C Suite Executive with 20 plus years of experience building, leading, and advising both public and private corporations through complex restructurings, acquisitions/divestitures, and capital market transactions. He currently is engaged as a “turn around” agent where he provides strategic advisory services to Boards and Management which include the establishment of Boards and their associated Governance and policies, strategic refreshes including restructuring, and instilling accountability for results. 

Earlier in his career Robert acted as both CFO and CEO to large public corporations (Ainsworth Lumber 2003-2009, TimberWest 2009-2012). He led the sale of TimberWest ($1.06 billion) and transitioned Ainsworth Lumber from a family-owned ($2 billion) Company. 

Mr. Allen holds a Bachelor of Science in Agriculture and a Master’s degree in Accounting from the University of British Columbia.
 

 

FIONA FITZMAURICE

 

Chief Financial Officer

Fiona Fitzmaurice is a chartered certified accountant with 12 years of experience in accounting and financial control. Fiona is currently CFO of Enforcer Gold Corp. (TSXV: VEIN) and acted previously as financial controller for Noront Resources Ltd. where she was involved in private placements, prospectus filings, flow-through financings and corporate audits. Prior to joining Noront, Fiona acted as a senior accountant and Controller for both private and publicly listed junior companies.

Fiona holds a BA in accounting and finance from the Athlone Institute of Technology in Ireland.

DANIEL PETROV

Director

Mr. Petrov has founded a number of successful Cannabis companies and most recently served as Executive Vice President at Aurora Cannabis Inc. (TSX: ACB) from prior to its listing onto the CSE until mid 2016.

Daniel is currently the CEO of Aura Health Studio, a medical marijuana dispensary licensed by the City of  Vancouver.

 

 

HIGH HAMPTON HOLDINGS
8 WELLINGTON STREET EAST,
TORONTO, ON, M5E 1C5,
CANADA
(416) 453-4708
[email protected]

View full HC profile View Profile
View All

Executive video interviews

VIEW ALL VIDEOS

© biotech Capital 2018

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.